RhumbLine Advisers’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-72,806
| Closed | -$4.94M | – | 2967 |
|
2019
Q3 | $4.94M | Buy |
72,806
+35,392
| +95% | +$2.4M | 0.01% | 1192 |
|
2019
Q2 | $2.18M | Buy |
37,414
+6,812
| +22% | +$396K | ﹤0.01% | 1692 |
|
2019
Q1 | $2.14M | Buy |
30,602
+895
| +3% | +$62.7K | ﹤0.01% | 1664 |
|
2018
Q4 | $1.91M | Buy |
29,707
+7,974
| +37% | +$513K | ﹤0.01% | 1672 |
|
2018
Q3 | $1.53M | Sell |
21,733
-260
| -1% | -$18.3K | ﹤0.01% | 1803 |
|
2018
Q2 | $1.11M | Buy |
21,993
+1,310
| +6% | +$66K | ﹤0.01% | 1963 |
|
2018
Q1 | $647K | Sell |
20,683
-340
| -2% | -$10.6K | ﹤0.01% | 2117 |
|
2017
Q4 | $719K | Sell |
21,023
-3,911
| -16% | -$134K | ﹤0.01% | 2092 |
|
2017
Q3 | $800K | Buy |
24,934
+270
| +1% | +$8.66K | ﹤0.01% | 2089 |
|
2017
Q2 | $803K | Buy |
24,664
+1,296
| +6% | +$42.2K | ﹤0.01% | 2064 |
|
2017
Q1 | $736K | Buy |
23,368
+502
| +2% | +$15.8K | ﹤0.01% | 2073 |
|
2016
Q4 | $672K | Buy |
22,866
+1,250
| +6% | +$36.7K | ﹤0.01% | 2070 |
|
2016
Q3 | $625K | Buy |
21,616
+55
| +0.3% | +$1.59K | ﹤0.01% | 2073 |
|
2016
Q2 | $558K | Buy |
21,561
+805
| +4% | +$20.8K | ﹤0.01% | 2128 |
|
2016
Q1 | $514K | Buy |
20,756
+70
| +0.3% | +$1.73K | ﹤0.01% | 2201 |
|
2015
Q4 | $728K | Buy |
20,686
+930
| +5% | +$32.7K | ﹤0.01% | 2014 |
|
2015
Q3 | $418K | Buy |
19,756
+7
| +0% | +$148 | ﹤0.01% | 2355 |
|
2015
Q2 | $549K | Buy |
19,749
+25
| +0.1% | +$695 | ﹤0.01% | 2264 |
|
2015
Q1 | $603K | Buy |
19,724
+2,300
| +13% | +$70.3K | ﹤0.01% | 2177 |
|
2014
Q4 | $557K | Sell |
17,424
-400
| -2% | -$12.8K | ﹤0.01% | 2214 |
|
2014
Q3 | $505K | Sell |
17,824
-100
| -0.6% | -$2.83K | ﹤0.01% | 2212 |
|
2014
Q2 | $491K | Sell |
17,924
-520
| -3% | -$14.2K | ﹤0.01% | 2281 |
|
2014
Q1 | $486K | Sell |
18,444
-820
| -4% | -$21.6K | ﹤0.01% | 2250 |
|
2013
Q4 | $564K | Hold |
19,264
| – | – | ﹤0.01% | 2183 |
|
2013
Q3 | $589K | Sell |
19,264
-99
| -0.5% | -$3.03K | ﹤0.01% | 2110 |
|
2013
Q2 | $614K | Buy |
+19,363
| New | +$614K | ﹤0.01% | 2106 |
|